• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

叶黄素纳米粒子在化学预防中的作用:体外和体内抗癌活性。

Luteolin nanoparticle in chemoprevention: in vitro and in vivo anticancer activity.

机构信息

Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, 1365 C Clifton Road, Atlanta, GA 30322.

出版信息

Cancer Prev Res (Phila). 2014 Jan;7(1):65-73. doi: 10.1158/1940-6207.CAPR-13-0230.

DOI:10.1158/1940-6207.CAPR-13-0230
PMID:24403290
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3888883/
Abstract

Cancer prevention (chemoprevention) by using naturally occurring dietary agents has gained immense interest because of the broad safety window of these compounds. However, many of these compounds are hydrophobic and poorly soluble in water. They frequently display low bioavailability, poor systemic delivery, and low efficacy. To circumvent this problem, we explored a novel approach toward chemoprevention using nanotechnology to deliver luteolin, a natural compound present in green vegetables. We formulated water-soluble polymer-encapsulated Nano-Luteolin from hydrophobic luteolin, and studied its anticancer activity against lung cancer and head and neck cancer. In vitro studies demonstrated that, like luteolin, Nano-Luteolin inhibited the growth of lung cancer cells (H292 cell line) and squamous cell carcinoma of head and neck (SCCHN) cells (Tu212 cell line). In Tu212 cells, the IC50 value of Nano-Luteolin was 4.13 μmol/L, and that of luteolin was 6.96 μmol/L. In H292 cells, the IC50 of luteolin was 15.56 μmol/L, and Nano-Luteolin was 14.96 μmol/L. In vivo studies using a tumor xenograft mouse model demonstrated that Nano-Luteolin has a significant inhibitory effect on the tumor growth of SCCHN in comparison to luteolin. Our results suggest that nanoparticle delivery of naturally occurring dietary agents like luteolin has many advantages and may have potential application in chemoprevention in clinical settings.

摘要

利用天然存在的饮食因子进行癌症预防(化学预防)因其化合物具有广泛的安全窗而引起了极大的兴趣。然而,许多这些化合物是疏水性的,在水中溶解度差。它们经常表现出低生物利用度、差的全身递送和低功效。为了克服这个问题,我们探索了一种使用纳米技术来传递叶黄素的新型化学预防方法,叶黄素是一种存在于绿色蔬菜中的天然化合物。我们从疏水性叶黄素中制备了水溶性聚合物包封的 Nano-Luteolin,并研究了其对肺癌和头颈部癌症的抗癌活性。体外研究表明,与叶黄素一样,Nano-Luteolin 抑制肺癌细胞(H292 细胞系)和头颈部鳞状细胞癌(SCCHN)细胞(Tu212 细胞系)的生长。在 Tu212 细胞中,Nano-Luteolin 的 IC50 值为 4.13 μmol/L,而叶黄素的 IC50 值为 6.96 μmol/L。在 H292 细胞中,叶黄素的 IC50 值为 15.56 μmol/L,而 Nano-Luteolin 的 IC50 值为 14.96 μmol/L。使用肿瘤异种移植小鼠模型的体内研究表明,与叶黄素相比,Nano-Luteolin 对 SCCHN 的肿瘤生长具有显著的抑制作用。我们的结果表明,像叶黄素这样的天然饮食因子的纳米粒子递送具有许多优势,并可能在临床环境中的化学预防中具有潜在的应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f9a/3888883/a2acf10fc966/nihms-539938-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f9a/3888883/23347d0998cb/nihms-539938-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f9a/3888883/30c5532dbbb1/nihms-539938-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f9a/3888883/c2785aa1894b/nihms-539938-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f9a/3888883/cbf2754832b7/nihms-539938-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f9a/3888883/a2acf10fc966/nihms-539938-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f9a/3888883/23347d0998cb/nihms-539938-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f9a/3888883/30c5532dbbb1/nihms-539938-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f9a/3888883/c2785aa1894b/nihms-539938-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f9a/3888883/cbf2754832b7/nihms-539938-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f9a/3888883/a2acf10fc966/nihms-539938-f0005.jpg

相似文献

1
Luteolin nanoparticle in chemoprevention: in vitro and in vivo anticancer activity.叶黄素纳米粒子在化学预防中的作用:体外和体内抗癌活性。
Cancer Prev Res (Phila). 2014 Jan;7(1):65-73. doi: 10.1158/1940-6207.CAPR-13-0230.
2
Enhanced anti-tumor activity by the combination of the natural compounds (-)-epigallocatechin-3-gallate and luteolin: potential role of p53.(-)-表没食子儿茶素-3-没食子酸酯和木犀草素联合增强抗肿瘤活性:p53 的潜在作用。
J Biol Chem. 2010 Nov 5;285(45):34557-65. doi: 10.1074/jbc.M110.141135. Epub 2010 Sep 8.
3
Chemoprevention of head and neck cancer.头颈部癌症的化学预防
Curr Oncol Rep. 2003 Mar;5(2):152-7. doi: 10.1007/s11912-003-0103-x.
4
Synthesis of a copolymer carrier for anticancer drug luteolin for targeting human breast cancer cells.合成一种用于抗癌药物木犀草素的共聚物载体,用于靶向人乳腺癌细胞。
J Tradit Chin Med. 2019 Aug;39(4):474-481.
5
Liposome encapsulated luteolin showed enhanced antitumor efficacy to colorectal carcinoma.脂质体包封的木犀草素显示出增强的抗肿瘤功效,可用于结直肠癌。
Mol Med Rep. 2018 Feb;17(2):2456-2464. doi: 10.3892/mmr.2017.8185. Epub 2017 Nov 29.
6
Chemoprevention targets for tobacco-related head and neck cancer: past lessons and future directions.烟草相关头颈癌的化学预防靶点:过去的经验教训与未来方向
Oral Oncol. 2015 Jun;51(6):557-64. doi: 10.1016/j.oraloncology.2015.02.101. Epub 2015 Apr 11.
7
A perspective on chemoprevention by resveratrol in head and neck squamous cell carcinoma.白藜芦醇对头颈部鳞状细胞癌的化学预防作用透视
Adv Exp Med Biol. 2015;815:333-48. doi: 10.1007/978-3-319-09614-8_19.
8
Chemoprevention of squamous cell carcinoma of the head and neck.头颈部鳞状细胞癌的化学预防
Curr Opin Oncol. 2007 May;19(3):180-7. doi: 10.1097/CCO.0b013e3280f01026.
9
Chemoprevention of Head and Neck Cancer: A Review of Current Approaches and Future Perspectives.头颈部癌症的化学预防:当前方法和未来展望的综述。
Cancer Prev Res (Phila). 2024 Oct 1;17(10):443-455. doi: 10.1158/1940-6207.CAPR-24-0093.
10
Clinical trials in chemoprevention of head and neck cancers.头颈部癌症化学预防的临床试验
Rev Recent Clin Trials. 2012 Aug;7(3):249-54. doi: 10.2174/157488712802281349.

引用本文的文献

1
Updated Review on Natural Polyphenols: Molecular Mechanisms, Biological Effects, and Clinical Applications for Cancer Management.天然多酚的最新综述:癌症管理的分子机制、生物学效应及临床应用
Biomolecules. 2025 Apr 28;15(5):629. doi: 10.3390/biom15050629.
2
Oxidative Stress and Dietary Antioxidants in Head and Neck Cancer.头颈癌中的氧化应激与膳食抗氧化剂
Antioxidants (Basel). 2025 Apr 24;14(5):508. doi: 10.3390/antiox14050508.
3
Luteolin: a natural product with multiple mechanisms for atherosclerosis.木犀草素:一种具有多种抗动脉粥样硬化机制的天然产物。

本文引用的文献

1
A novel combinatorial nanotechnology-based oral chemopreventive regimen demonstrates significant suppression of pancreatic cancer neoplastic lesions.一种新型组合纳米技术为基础的口服化学预防方案显示出对胰腺癌肿瘤病变的显著抑制作用。
Cancer Prev Res (Phila). 2013 Oct;6(10):1015-1025. doi: 10.1158/1940-6207.CAPR-13-0172. Epub 2013 Sep 26.
2
Nanoparticle delivery of cancer drugs.癌症药物的纳米颗粒递药系统。
Annu Rev Med. 2012;63:185-98. doi: 10.1146/annurev-med-040210-162544. Epub 2011 Sep 1.
3
Celecoxib promotes c-FLIP degradation through Akt-independent inhibition of GSK3.
Front Pharmacol. 2025 Mar 27;16:1503832. doi: 10.3389/fphar.2025.1503832. eCollection 2025.
4
An In Vitro and In Silico Study of Luteolin-Loaded Zinc Oxide Nanoparticles: Enhancing Bioactivity and Efficacy for Advanced Therapeutic Applications Against Cariogenic Microorganisms.载木犀草素的氧化锌纳米颗粒的体外和计算机模拟研究:增强对致龋微生物的生物活性和高级治疗应用的疗效
Cureus. 2024 Aug 28;16(8):e68058. doi: 10.7759/cureus.68058. eCollection 2024 Aug.
5
Network pharmacology: an efficient but underutilized approach in oral, head and neck cancer therapy-a review.网络药理学:口腔、头颈癌治疗中一种高效但未充分利用的方法——综述
Front Pharmacol. 2024 Jul 5;15:1410942. doi: 10.3389/fphar.2024.1410942. eCollection 2024.
6
Development of Polymeric Micelles for Combined Delivery of Luteolin and Doxorubicin for Cancer Therapy.用于癌症治疗的木犀草素和阿霉素联合递送的聚合物胶束的研发
J Cancer. 2024 Jul 8;15(14):4717-4730. doi: 10.7150/jca.96402. eCollection 2024.
7
The Recent Development of Luteolin-loaded Nanocarrier in Targeting Cancer.芦丁载药纳米载体在癌症靶向治疗中的最新进展。
Curr Pharm Des. 2024;30(27):2129-2141. doi: 10.2174/0113816128313713240628063301.
8
Revisiting luteolin: An updated review on its anticancer potential.重新审视木犀草素:关于其抗癌潜力的最新综述。
Heliyon. 2024 Feb 20;10(5):e26701. doi: 10.1016/j.heliyon.2024.e26701. eCollection 2024 Mar 15.
9
Natural products for the treatment of chemotherapy-related cognitive impairment and prospects of nose-to-brain drug delivery.用于治疗化疗相关认知障碍的天然产物及鼻脑给药的前景
Front Pharmacol. 2024 Jan 29;15:1292807. doi: 10.3389/fphar.2024.1292807. eCollection 2024.
10
Luteolin-Loaded Nanoparticles for the Treatment of Melanoma.叶黄素纳米载药用于治疗黑色素瘤。
Int J Nanomedicine. 2023 Apr 20;18:2053-2068. doi: 10.2147/IJN.S400329. eCollection 2023.
塞来昔布通过 Akt 非依赖性抑制 GSK3 促进 c-FLIP 的降解。
Cancer Res. 2011 Oct 1;71(19):6270-81. doi: 10.1158/0008-5472.CAN-11-0838. Epub 2011 Aug 25.
4
Luteolin induced G2 phase cell cycle arrest and apoptosis on non-small cell lung cancer cells.木樨草素诱导非小细胞肺癌细胞 G2 期细胞周期阻滞和凋亡。
Toxicol In Vitro. 2011 Oct;25(7):1385-91. doi: 10.1016/j.tiv.2011.05.009. Epub 2011 May 13.
5
Inhibition of cell survival, invasion, tumor growth and histone deacetylase activity by the dietary flavonoid luteolin in human epithelioid cancer cells.膳食类黄酮木樨草素抑制人上皮样癌细胞的细胞存活、侵袭、肿瘤生长和组蛋白去乙酰化酶活性。
Eur J Pharmacol. 2011 Jan 25;651(1-3):18-25. doi: 10.1016/j.ejphar.2010.10.063. Epub 2010 Nov 11.
6
Enhanced anti-tumor activity by the combination of the natural compounds (-)-epigallocatechin-3-gallate and luteolin: potential role of p53.(-)-表没食子儿茶素-3-没食子酸酯和木犀草素联合增强抗肿瘤活性:p53 的潜在作用。
J Biol Chem. 2010 Nov 5;285(45):34557-65. doi: 10.1074/jbc.M110.141135. Epub 2010 Sep 8.
7
Luteolin induces G1 arrest in human nasopharyngeal carcinoma cells via the Akt-GSK-3β-Cyclin D1 pathway.木樨草素通过 Akt-GSK-3β-Cyclin D1 通路诱导人鼻咽癌细胞 G1 期阻滞。
Cancer Lett. 2010 Dec 8;298(2):167-75. doi: 10.1016/j.canlet.2010.07.001. Epub 2010 Jul 23.
8
Proteomic analysis reveals ATP-dependent steps and chaperones involvement in luteolin-induced lung cancer CH27 cell apoptosis.蛋白质组学分析揭示了三磷酸腺苷依赖性步骤和伴侣蛋白在木樨草素诱导的肺癌 CH27 细胞凋亡中的作用。
Eur J Pharmacol. 2010 Sep 10;642(1-3):19-27. doi: 10.1016/j.ejphar.2010.05.053. Epub 2010 Jun 8.
9
Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.环肽 RGD 修饰的聚乙二醇-共-聚乳酸胶束增强紫杉醇抗脑胶质瘤作用。
J Control Release. 2010 Apr 2;143(1):136-42. doi: 10.1016/j.jconrel.2009.12.020. Epub 2010 Jan 7.
10
Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions.绿茶提取物治疗高危口腔癌前病变患者的 II 期随机、安慰剂对照试验。
Cancer Prev Res (Phila). 2009 Nov;2(11):931-41. doi: 10.1158/1940-6207.CAPR-09-0121.